AYLo - AutoimmunitY and Loss of y

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2026

Conditions
Giant Cell Arteritis (GCA)Polymyalgia Rheumatica (PMR)ANCA Associated Vasculitis (AAV)Idiopathic Inflammatory MyopathiesIgG4-Related DiseasesRheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)Connective Tissue DiseaseSarcoidosisInterstitial Lung Disease Due to Systemic Disease (Disorder)Interstitial Lung Disease (ILD)Asthma BronchialeCOPD
Interventions
DIAGNOSTIC_TEST

Single nucleotide polymorphisms (SNP)

Utilizing single nucleotide polymorphisms (SNP) genotyping mosaic loss of y (mLOY) of individual patient will be assessed.

DIAGNOSTIC_TEST

3'mRNA sequencing

3'mRNA sequencing analyzes gene expression profiles related to the immune response in different study cohorts, aiding in understanding the genetic underpinnings of inflammation and its association with mLOY.

DIAGNOSTIC_TEST

Enzyme-linked immunosorbent assay (ELISA) and Legendplex Array

Used to measure cytokine levels in the serum of investigated patients, aiding in profiling inflammatory markers that are indicative of disease activity, response to treatment and consequence of mLOY..

DIAGNOSTIC_TEST

Flow Cytometry

Employed to analyze immune cell phenotypes in investigated cohorts. This test helps identify various immune cell subsets and their activation states, which are critical for understanding disease mechanisms and its association with mLOY.

DIAGNOSTIC_TEST

Laboratory assessment

Serum Chemistry

DIAGNOSTIC_TEST

Assessment of Pulmonary Involvement

Results of routine clinical assessment of pulmonary involvement (such as lung ultrasound, computed tomography, chest x-ray, whole-body plethysmography) will be compared to mLOY, ELISA/ Legendplex/ flow cytometry/ transcriptome analysis results.

Trial Locations (1)

53127

RECRUITING

Department of Rheumatology, Bonn

All Listed Sponsors
lead

University of Bonn

OTHER

NCT06696027 - AYLo - AutoimmunitY and Loss of y | Biotech Hunter | Biotech Hunter